Erector Spinae Plane Block Supplementation to General Anaesthesia in Percutaneous Nephrolithotomy Surgery for Post-Operative Quality of Recovery
International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)
DOI: 10.25258/ijcpr.18.7.69 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Mamta Agrawal und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Percutaneous nephrolithotomy (PCNL) is associated with substantial early postoperative pain and frequent opioid requirements that can delay recovery. Various analgesic techniques have been advocated as adjuncts to general anaesthesia in PCNL surgery. Regional anaesthesia plays a crucial role in enhancing patient care, improving the quality of treatment, and increasing patient satisfaction. The erector spinae plane block (ESPB) may offer opioid-sparing analgesia and improve quality of recovery, but its impact on patient-centred outcomes after PCNL remains insufficiently defined.
Objective
To determine whether ESPB with 0.25% levobupivacaine, when added to general anaesthesia (GA), improves postoperative quality of recovery (QoR-15) compared with GA alone in adults undergoing elective PCNL.
Methods
The study was conducted after receiving Institutional Ethics Committee approval and CTRI trial registration. Single-centre, prospective, randomized, parallel-group study was conducted at People’s College of Medical Science & Research Centre in India. Sixty adults (18–60 years, ASA I–II) scheduled for elective PCNL are randomized 1:1 to GA + ESPB (Group E) or GA only (Group C). ESPB is being performed after induction at the L1 level using 20 mL of 0.25% levobupivacaine. The primary outcome is QoR-15 on the day of discharge. Secondary outcomes include pain intensity at0 hr and every 4 hr to 24 hr, time to first rescue opioid, cumulative tramadol at 24 hr and 48 hr, postoperative nausea and vomiting, immediate postoperative haemodynamics, adverse events, and length of stay. Analyses were intention-to-treat (α=0.05).
Results
All randomized patients completed the primary outcome. QoR-15 at discharge was higher with ESPB (124.8±10.7) than control (115.7±12.3); mean difference 9.1 (95% CI, 3.7–14.4; p=0.001), exceeding the 8point MCID. ESPB reduced pain at PACU/0 hr (mean difference −1.6, 95% CI −2.3 to −0.9; p
Zitieren
APA
Agrawal, M., Pandey, A., Lawania, Y., Batra, M., & Nair, A. K. (2026). Erector Spinae Plane Block Supplementation to General Anaesthesia in Percutaneous Nephrolithotomy Surgery for Post-Operative Quality of Recovery. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.69
Vancouver
Agrawal M, Pandey A, Lawania Y, Batra M, Nair AK. Erector Spinae Plane Block Supplementation to General Anaesthesia in Percutaneous Nephrolithotomy Surgery for Post-Operative Quality of Recovery. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.69
BibTeX
@article{Agrawal2026,
author = {Agrawal, Mamta and Pandey, Anupam and Lawania, Yashasvini and Batra, Mahima and Nair, Ashwin Krishnan},
title = {Erector Spinae Plane Block Supplementation to General Anaesthesia in Percutaneous Nephrolithotomy Surgery for Post-Operative Quality of Recovery},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {07},
doi = {10.25258/ijcpr.18.7.69}
}
EUVIMED